Breast cancer recurrence risk lingers for years after treatment

The risk of breast cancer recurrence remains considerable in women after completing the standard five years of endocrine therapy, a review has found.

Breast cancer recurrences occurred at a steady rate for 15 years after being disease free with endocrine therapy, according to the meta-analysis of 88 studies involving more than 60,000 women with low-grade oestrogen receptor-positive breast cancer.

The absolute risk of cancer recurring was dependent on the original tumour status and grade, increasing